NS Medical Consultancy Limited 13977579 false 2024-04-01 2025-03-31 2025-03-31 The principal activity of the company is Management consultancy activities other than financial management & General medical practice activities Digita Accounts Production Advanced 6.30.9574.0 true 13977579 2024-04-01 2025-03-31 13977579 2025-03-31 13977579 bus:OrdinaryShareClass1 2025-03-31 13977579 core:CurrentFinancialInstruments core:WithinOneYear 2025-03-31 13977579 core:FurnitureFittingsToolsEquipment 2025-03-31 13977579 bus:SmallEntities 2024-04-01 2025-03-31 13977579 bus:AuditExemptWithAccountantsReport 2024-04-01 2025-03-31 13977579 bus:FilletedAccounts 2024-04-01 2025-03-31 13977579 bus:SmallCompaniesRegimeForAccounts 2024-04-01 2025-03-31 13977579 bus:RegisteredOffice 2024-04-01 2025-03-31 13977579 bus:CompanySecretaryDirector1 2024-04-01 2025-03-31 13977579 bus:OrdinaryShareClass1 2024-04-01 2025-03-31 13977579 bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 13977579 bus:Agent1 2024-04-01 2025-03-31 13977579 core:FurnitureFittings 2024-04-01 2025-03-31 13977579 core:FurnitureFittingsToolsEquipment 2024-04-01 2025-03-31 13977579 countries:EnglandWales 2024-04-01 2025-03-31 13977579 2024-03-31 13977579 core:FurnitureFittingsToolsEquipment 2024-03-31 13977579 2023-04-01 2024-03-31 13977579 2024-03-31 13977579 bus:OrdinaryShareClass1 2024-03-31 13977579 core:CurrentFinancialInstruments core:WithinOneYear 2024-03-31 13977579 core:FurnitureFittingsToolsEquipment 2024-03-31 iso4217:GBP xbrli:pure xbrli:shares

Registration number: 13977579

NS Medical Consultancy Limited

trading as NS Medical Limited

Unaudited Filleted Abridged Financial Statements

for the Year Ended 31 March 2025

 

NS Medical Consultancy Limited

trading as NS Medical Limited

Contents

Company Information

1

Abridged Balance Sheet

2

Notes to the Unaudited Abridged Financial Statements

3 to 5

 

NS Medical Consultancy Limited

trading as NS Medical Limited

Company Information

Director

Navina Sullivan

Company secretary

Navina Sullivan

Registered office

Charles Rippin & Turner
Middlesex House
130 College Road
Harrow
Middlesex
HA1 1BQ

Accountants

Charles Rippin and Turner Limited Charles Rippin & Turner
Middlesex House
130 College Road
Harrow
Middlesex
HA1 1BQ

 

NS Medical Consultancy Limited

trading as NS Medical Limited

(Registration number: 13977579)
Abridged Balance Sheet as at 31 March 2025

Note

2025
£

2024
£

Fixed assets

 

Tangible assets

4

43,253

45,456

Current assets

 

Cash at bank and in hand

 

28,258

19,256

Creditors: Amounts falling due within one year

(565)

(2,318)

Net current assets

 

27,693

16,938

Total assets less current liabilities

 

70,946

62,394

Accruals and deferred income

 

(3,970)

(3,600)

Net assets

 

66,976

58,794

Capital and reserves

 

Called up share capital

5

50

50

Retained earnings

66,926

58,744

Shareholders' funds

 

66,976

58,794

For the financial year ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The director acknowledges their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

All of the company’s members have consented to the preparation of an Abridged Balance Sheet in accordance with Section 444(2A) of the Companies Act 2006.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the director has not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the director on 8 May 2025
 

.........................................
Navina Sullivan
Company secretary and director

 

NS Medical Consultancy Limited

trading as NS Medical Limited

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 March 2025

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
Charles Rippin & Turner
Middlesex House
130 College Road
Harrow
Middlesex
HA1 1BQ

These financial statements were authorised for issue by the director on 8 May 2025.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These abridged financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These abridged financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tax

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

 

NS Medical Consultancy Limited

trading as NS Medical Limited

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 March 2025

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Fixtures and fittings

12% Reducing balance

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Borrowings

Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the profit and loss account over the period of the relevant borrowing.

Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.

Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

 

NS Medical Consultancy Limited

trading as NS Medical Limited

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 March 2025

3

Staff numbers

The average number of persons employed by the company (including the director) during the year, was 1 (2024 - 1).

4

Tangible assets

Furniture, fittings and equipment
 £

Total
£

Cost or valuation

At 1 April 2024

49,607

49,607

Additions

1,440

1,440

At 31 March 2025

51,047

51,047

Depreciation

At 1 April 2024

4,151

4,151

Charge for the year

3,643

3,643

At 31 March 2025

7,794

7,794

Carrying amount

At 31 March 2025

43,253

43,253

At 31 March 2024

45,456

45,456

5

Share capital

Allotted, called up and fully paid shares

2025

2024

No.

£

No.

£

Ordinary shares of £1 each

50

50

50

50